key: cord-0989421-dmnj2nb3 authors: Fernandez, Ignacio Javier; Spagnolo, Federico; Valerini, Sara; Mattioli, Francesco; Molteni, Gabriele; Marchioni, Alessandro; Lucidi, Daniela title: SARS‐CoV‐2 tracheitis in laryngectomised patients: A consecutive case‐series study date: 2021-09-27 journal: Clin Otolaryngol DOI: 10.1111/coa.13858 sha: c56f70ee957060138794e05e063f437762bc45bb doc_id: 989421 cord_uid: dmnj2nb3 SARS-CoV-2 is a possible cause of acute severe tracheitis in laryngectomees. In our series, the clinical picture was characterized by a haemorrhagic tracheitis with a slow resolution pattern. We observed a histological pattern of erosive inflammation of the respiratory epithelium. Planned tracheo-bronchoscopy and tracheal toilettes are recommended to prevent critical obstruction of the airway, which can be fatal in patients with associated impairment of lung function caused by SARS-CoV-2 infection. The present cases highlight the need for close interdisciplinary working and communication in the management of airway complications of COVID-19 infection. After total laryngectomy (TL), the changes in the physiology of the tracheal epithelium due to the direct air passage through the stoma, loss of nasal humidification and impairment of the mucociliary clearance may increase the risk of lower respiratory tract infections. 1, 2 Tracheitis represents a challenging condition with urgent management and hospitalisation and can be complicated by significant crusting and airway occlusion. Total laryngectomy patients represent a unique challenge during the SARS-CoV-2 pandemic. On the one hand, they have a higher exposure to the contagion through respiratory droplets and aerosols, and a high risk of mortality due to the elderly age and comorbidities. 3 On the other hand, they carry a high risk of transmitting viral particles to healthcare staff through the tracheostoma. SARS-CoV-2 antigens have been identified in tracheal epithelial cells of infected patients. 4 Also, evidences of acute and chronic tracheitis due to SARS-CoV-2 involvement of the tracheal mucosa have been shown in post-mortem examinations. 5 A previous study 6 demonstrated signs of a tracheobronchitis in a COVID-19+ patient, detected by lung scintigraphy. These reports, together with the experience collected during the pandemic peak, prompted us to conduct a review of patients who presented at our institution for acute tracheitis after TL and concomitant SARS- Herein, we describe the clinical features of a series of TL patients who contracted SARS-CoV-2 and developed severe tracheitis, focusing on its management, clinical course and histological features. This is a retrospective study on patients subjected to TL who presented with acute tracheitis and concomitant positive testing for SARS-CoV-2. Patients were hospitalised at the University Hospital of Modena between September 2020 and January 2021. Inclusion criteria were as follows: patients subjected to TL, patients who underwent SARS-CoV-2 status assessment by combined nasal and tracheal swab and tested positive, patients who required hospitalisation, patients whose diagnosis of tracheitis was confirmed by means of an otolaryngologist evaluation including fibreoptic tracheoscopy or tracheobronchoscopy, and patients whose full clinical data were available. Were excluded from the study patients requiring hospitalisation, and who developed SARS-CoV-2 infection during their hospital stay (testing negative at admission). Patients' demographic, clinical and surgical information was retrospectively reviewed from clinical charts. Local Ethics Committee approval was obtained on December 2020 (576/2020/OSS/ AOUMO). Written informed consent was obtained from all patients. The study was conducted following the CARE guidelines. 7 Six patients were hospitalised for tracheitis after TL and tested positive for COVID-19 during the reporting period. Five cases were considered eligible, and a retrospective analysis of their clinical charts was performed. One patient was excluded for missing clinical data. Detailed clinical and laboratory data are reported in Table 1 . The median age of patients was 77 years (range = 64-82 years). The median time from TL was 2 years (range = 1-9 years). All patients referred at the emergency room (ER) of our institution. The diagnosis of SARS-CoV-2 infection was made in the ER. All patients presented with significant oxygen desaturation at admission (0 2 level <90%), three had fever and cough, one had thoracic pain, and one had bleeding from the tracheostoma. All patients underwent at least one CT scan examination of the chest. In all cases, a prompt ENT assessment, including fibre-optic evaluation through the stoma, was over the tracheostoma in all cases, as well as aerosol administration of mucolytics and hyaluronic acid solutions. In all cases, intravenous pharmacological therapy, including wide-spectrum antibiotics and high-dose steroids, was administered. In 4 cases, anticoagulants (low molecular weight heparin at a prophylactic dose) were also indicated. In three patients, microbiologic analysis of the tracheobronchial aspiration material was available, resulting in two cases in a multiagent bacterial superinfection and no infection detected in one case. In four patients, a serological assessment for testing other respiratory viruses (influenza A virus, respiratory syncytial virus, rhinoviruses, parainfluenza viruses, adenoviruses, bocaviruses and metapneumovirus) was performed, with negative results. In the present paper, we described a series of five laryngectomees None. The authors have no conflict of interest to declare Local Ethics Committee approval was obtained on December 2020 (576/2020/OSS/AOUMO) IJF and DL study design and drafting the article; FS and SV data collection; FM and GM data collection and data interpretation; AM critical review of the article from pneumological perspective. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Mucociliary clearance and mucosal surface characteristics before and after total laryngectomy Incidence of severe tracheobronchitis and pneumonia in laryngectomized patients: a retrospective clinical study and a European-wide survey among head and neck surgeons Safe management of laryngectomized patients during the COVID-19 pandemic On the whereabouts of SARS-CoV-2 in the human body: a systematic review Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection The CARE guidelines: consensus-based clinical case report guideline development Multidisciplinary safety recommendations after tracheostomy during COVID-19 pandemic: State of the art review COVID-19 and total laryngectomy-a report of two cases Appearance and management of COVID-19 laryngotracheitis: two case reports SARS-CoV-2 tracheitis in laryngectomised patients: A consecutive case-series study